Neuberger International Core Equity ETF
NBIE - ETF AI Analysis
Top Page
Neuberger International Core Equity ETF (NBIE)
NBIE, the Neuberger International Core Equity ETF, has a solid overall rating driven mainly by strong, diversified holdings like Novartis, ABB, and Roche, which show healthy financial performance, good profitability, and supportive technical trends. The fund also benefits from stable names such as Shell, Mitsubishi UFJ, and Tesco, though some holdings face issues like short-term bearish momentum, overvaluation risks, or revenue and cash flow challenges. The main risk factor is its meaningful exposure to large international companies where valuation concerns and occasional overbought or weak technical signals could lead to short-term volatility.
NBIE vs. SPDR S&P 500 ETF (SPY)
- AUM
- 243.76M
- Region
- Developed Markets
- Expense Ratio
- 0.29%
- Beta
- 0.63
- Issuer
- Neuberger Berman
- Inception Date
- Mar 06, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
NBIE Summary
NBIE is the Neuberger International Core Equity ETF, an actively managed fund that invests in a wide mix of companies from developed markets outside the U.S., such as Japan, the UK, and Europe. It doesn’t track a single index, but follows a broad international stock market theme, holding well-known names like ASML and Shell. Investors might consider NBIE for long-term growth and diversification beyond the U.S., since it spreads money across many countries and sectors. A key risk is that international stocks can be volatile and are affected by currency swings and global political and economic events, so the value can go up and down.
How much will it cost me?
This ETF has an expense ratio of 0.29%, which means you’ll pay about $2.90 per year for every $1,000 you invest. That’s a bit higher than the average index ETF because this fund is actively managed, with a research team selecting international stocks rather than just tracking a simple market index.
What would affect this ETF?
This ETF could benefit if developed markets outside the U.S. experience steady economic growth, which would support its broad mix of financial, industrial, health care, and technology companies, and if global demand for areas like semiconductors, energy, and materials remains strong for holdings such as ASML, Shell, and BHP. On the other hand, slower growth or recessions in Europe and other developed regions, currency swings versus the U.S. dollar, tighter regulations on banks, energy, or health care, or geopolitical tensions affecting international trade could weigh on the fund’s performance.
NBIE Top 10 Holdings
NBIE leans heavily on a handful of international blue chips, with ASML acting as the main engine: its strong year-to-date run, even after some recent choppiness, gives the fund a clear semiconductor tilt. Health care names like Roche and Novartis are steadily adding ballast, helping smooth out volatility. On the flip side, ABB and BHP have been more mixed lately, occasionally taking some wind out of the fund’s sails. With holdings spread across Europe, Japan, and other developed markets outside the U.S., NBIE offers broad global exposure without relying on any single country.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 3.40% | $8.00M | EUR 525.92B | 51.88% | 76Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:NOVN | Novartis AG | 2.33% | $5.47M | CHF 245.70B | 26.78% | 80Outperform |
 GB:SHEL | Shell (UK) | 2.01% | $4.72M | GBP 207.54B | 30.08% | 73Outperform |
 AU:BHP | BHP Group Ltd | 1.88% | $4.41M | AUD 303.03B | 35.84% | 68Neutral |
 GB:GSK | GlaxoSmithKline | 1.50% | $3.53M | GBP 76.21B | 5.58% | 77Outperform |
 DE:DHL | DHL Group | 1.39% | $3.26M | EUR 67.76B | 36.67% | 76Outperform |
 SE:ABB | ABB Ltd | ― | ― | ― | ― | 78Outperform |
 IT:ISP | Intesa Sanpaolo SpA | 1.36% | $3.20M | EUR 108.10B | 4.73% | 76Outperform |
 UBS | UBS Group AG | ― | ― | ― | ― | 73Outperform |
NBIE Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NBIE, the sentiment is Positive. The current price of 26.68 is above the 20-day moving average (MA) of 26.59, below the 50-day MA of 26.71, and compared to the 200-day MA of , indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 50.82 is Neutral, neither overbought nor oversold. The STOCH value of 61.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NBIE.
NBIE Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| NBIE | $26.68 | $29.00(8.70% Upside) | $243.76M | 0.29% | 70Outperform |
 FYLD | $39.81 | $43.31(8.78% Upside) | $752.75M | 0.59% | 62Neutral |
 TXUE | $35.54 | $39.32(10.65% Upside) | $604.18M | 0.65% | 65Neutral |
 AVSD | $79.67 | $90.64(13.76% Upside) | $377.10M | 0.23% | 65Neutral |
 DXIV | $71.96 | $83.30(15.76% Upside) | $241.53M | 0.30% | 62Neutral |
 RINT | $31.98 | $39.00(21.96% Upside) | $169.59M | 0.49% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NBIE | Neuberger International Core Equity ETF | 26.68 | 1.81 | 7.26% | |
| FYLD | Cambria Foreign Shareholder Yield ETF | 39.81 | 9.12 | 29.73% | |
| TXUE | Thornburg International Equity ETF | 35.54 | 5.39 | 17.89% | |
| AVSD | Avantis Responsible International Equity ETF | 79.67 | 10.40 | 15.01% | |
| DXIV | Dimensional International Vector Equity ETF | 71.96 | 11.66 | 19.35% | |
| RINT | International Developed Equity Active ETF | 31.98 | 4.15 | 14.91% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.